Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Flutamide rarely causes liver toxicity in prostate cancer patients.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.